Berkshire Hathaway Inc.
BRK-AHIGH VELOCITYFILING INTENSITYBerkshire Hathaway Inc. reads as an High Velocity (composite 78/100); Platform Builder deploying $0 across 1 disclosed transactions, running flat vs the prior cycle · primary market Insurance.
Lens
Disclosed M&A capital (2023–2025)
N/A
vs N/A in 2020–2022
Disclosed transactions
1
1/3 active fiscal years in window
Buyer archetype
Platform Builder
Large and recent disclosed spend expands platforms or service-line scale.
Composite score
78
High Velocity dominates · Filing Intensity
Behavioral posture, nine reads.
Each index scores the issuer 0–100 against an EDGAR-anchored definition. Scores ≥ threshold elevate the issuer into the index's constituent set; the dominant index drives the masthead label.
Active Acquirer
Companies actively deploying disclosed capital into M&A
- $16.2B disclosed buyer spend
- Filed within 19d
Buyer Cadence
Buyer-side companies with recent filing activity
- Filed within 19d
- 20 acquisition-history signals
- 176 8-Ks
Target Probability
Issuers showing target-side patterns from filings
- 105 activism filings
Spin/Carve
Issuers showing spin-off, carve-out, or sum-of-parts posture
- 105 activism filings
Pressure Watch
Issuers facing activism, governance, or control pressure
- 105 activism filings
- Latest activism 1.5y ago
Distress Watch
Issuers showing financial-distress filing patterns
- 105 activism filings
Restatement Risk
Issuers with accounting-integrity flags from filings
Capital Velocity
DominantIssuers with the highest filing-activity intensity
- 176 8-Ks
- Filed within 19d
- 5 form types
Quiet Power
Large issuers with low signal volume and clean disclosure cadence
- Enterprise value $1.1T
- 10-Q 22d ago
- 2 active signals
Capital cadence.
No disclosed M&A capital in the 10-year window.
This issuer has not disclosed material acquisition spend or count in the last ten fiscal years.
Strategy posture.
The buyer's playbook in terms of strategic archetype: what each disclosed move says about how they're deploying capital.
Archetype mix
- Bolt On25%
- Geographic Expansion25%
- Platform25%
- Technology Acquisition25%
Strategy keywords
Terms recurring across recent 10-K acquisition disclosures.
- bolt_on
- geographic_expansion
- horizontal_consolidation
- platform
Filing language.
Direct excerpts from acquisition disclosures and strategy sections: the verbs the buyer chose, in the filings they signed.
“On August 1, 2014, Lubrizol completed the acquisition of Vesta, a leading contract manufacturer of silicone medical products and thermoplastic extruded components for the medical device industry.”
“MiTek has completed a number of bolt-on acquisitions in the past five years, intended to diversify product offerings and reduce the impact of the cyclical global housing markets.”
“On September 4, 2015, Lubrizol completed the acquisition of Particle Sciences, a leading contract drug development and manufacturing organization.”
“BHRG has negotiated the acquisition of certain property and casualty insurance businesses in run-off”
“Lubrizol has completed a number of bolt-on acquisitions, including three in 2014.”
Market context.
Where this issuer sits inside its SE-Cluster rollup wedge, with disclosed-spend rank plus trading comparables against the public peer set.
Primary market
Insurance
- Market spend (2023–2025)
- $50.4B
- Market spend (2020–2022)
- $62.2B
- Recent vs prior
- −19%
- Issuer rank in market
- N/A
- Share of market capital
- 0.0%
Valuation positioning
BRK-A trades at a -9.2-turn discount to the Insurance peer median of 23.9×.
- EV / Revenue
- 3.0×
- Net debt / EBITDA
- N/A
- Peer median EV / EBITDA
- 23.9×
Trading comparables
FMP market data · 2026-05-10
| Company | EV / EBITDA | EV / Rev | Net debt / EBITDA | Revenue | M&A 2023–2025 |
|---|---|---|---|---|---|
| 29.5× | 6.4× | 2.1× | $70.8B | $156M | |
| 23.9× | 4.3× | 3.3× | $36.8B | $11.8B | |
3m CompanyMMM | 16.6× | 3.3× | 1.4× | $25B | N/A |
Berkshire Hathaway Inc.BRK-A | 14.8× | 3.0× | N/A | $375.4B | N/A |
Trading multiples from FMP market data; disclosed M&A spend from the SE-Cluster EDGAR 10-K corpus. Peer set = top disclosed buyers in Insurance. Bars scaled to the highest EV/EBITDA in the set.
Target landscape.
Public-issuer targets that fit this buyer's archetype and target categories from filing-derived signal. Scores reflect cross-signal fit; reasons cite the EDGAR-anchored facts that drove the match.
No qualifying public-issuer targets surfaced from the current signal mix.
Stated target categories
No target categories enumerated in the audited corpus for this issuer.
Filing activity & signal stream.
Filing cadence and event-driven signals visible on EDGAR. The signal stream below is curated from restatement / spin-carve / activism categories, providing context for any near-term call.
Filing cadence
- 10-K (annual)282026-03-02
- 10-Q (quarterly)832026-05-04
- 8-K (event)1762026-05-07
- Proxy / DEF 14A402026-03-13
- Activism (13D / DFAN / PREC)1052024-11-25
Signals on file
- elevated
Activism on file
2024-11-25105 activist filings on file (13D, DFAN14A, PREC14A series).
- info
Signal
Disclosed acquisition spend
- info
Signal
10-K strategy themes
Audited corpus.
No audited record on file for this CIK in the current v6 corpus.
This issuer has not been extracted into the v6 audited acquirer corpus yet. The brief above pulls from ranking-level aggregates and issuer-index signal only.